Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation

Circulation: Cardiovascular Interventions

Volumn 5, Issue 5, 2012, Pages 663-671

  Kuramitsu, Shoichi ^a   Iwabuchi, Masashi ^a   Haraguchi, Takuya ^b   Domei, Takenori ^a   Nagae, Ayumu ^b   Hyodo, Makoto ^a   Yamaji, Kyohei ^a   Soga, Yoshimitsu ^a   Arita, Takeshi ^a   Shirai, Shinichi ^a,c   Kondo, Katsuhiro ^a   Ando, Kenji ^a   Sakai, Koyu ^a   Goya, Masahiko ^a   Takabatake, Yoshitaka ^b   Sonoda, Shinjo ^a   Yokoi, Hiroyoshi ^a   Toyota, Fumitoshi ^b   Nosaka, Hideyuki ^a   Nobuyoshi, Masakiyo ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b Chidoribashi Byoin   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Everolimus eluting stent; Stent fracture; Stent thrombosis

Indexed keywords

EVEROLIMUS; PROMUS; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY CALCIFICATION; DRUG ELUTING STENT; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; STENT FRACTURE; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; SIROLIMUS; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR CALCIFICATION;

EID: 84868643700     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.112.969238     Document Type: Article

References (36)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R; RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revasculariza-tion. N Engl J Med. 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;49:315-323.
3. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Sud-dath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, Serruys PW. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519-1521. (Pubitemid 39410418)
4. James SK, Stenestrand U, Lindbäck J, Carlsson J, Scherstén F, Nilsson T, Wallentin L, Lagerqvist B; SCAAR Study Group. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009;360:1933-1945.
5. Lee SE, Jeong MH, Kim IS, Ko JS, Lee MG, Kang WY, Kim SH, Sim DS, Park KH, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Ahn YK, Cho JG, Park JC, Kang JC. Clinical outcomes and optimal treatment for stent fracture after drug-eluting stent implantation. J Cardiol. 2009;53:422-428.
6. Aoki J, Nakazawa G, Tanabe K, Hoye A, Yamamoto H, Nakayama T, Onu-ma Y, Higashikuni Y, Otsuki S, Yagishita A, Yachi S, Nakajima H, Hara K. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007;69:380-386. (Pubitemid 46339279)
7. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv. 2007;69:387-394. (Pubitemid 46339280)
8. Lee SH, Park JS, Shin DG, Kim YJ, Hong GR, Kim W, Shim BS. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol. 2007;100:627-630. (Pubitemid 47223137)
9. Okumura M, Ozaki Y, Ishii J, Kan S, Naruse H, Matsui S, Ishikawa M, Hattori K, Gochi T, Nakano T, Yamada A, Kato S, Motoyama S, Sarai M, Takagi Y, Ismail TF, Nomura M, Hishida H. Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation. Circ J. 2007;7; 1:1669-1677.
10. Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ, Simonton CA, Garg J, Lokhnygina Y, Mancini GB, Yeoh E, Buller CE; ACROSS/TOSCA-4 Investigators. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. JACC Cardiovasc Interv. 2009;2:97-106.
11. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol. 2009;103:923-929.
12. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I, Kolod-gie FD, Virmani R. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009;54:1924-1931.
13. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 2010;56 (10 Suppl):S1-42.
14. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT III Investigators. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Evero-limus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation. 2009;119:680-686.
15. Kedhi E, Joesoef KS, McFadden E, Wassing J, Van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-elut-ing stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010;375:201-209.
16. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pich-Ard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872-1878. (Pubitemid 29511140)
17. Ino Y, Kubo T, Kitabata H, Shimamura K, Shiono Y, Orii M, Okochi K, Sougawa H, Tanimoto T, Komukai K, Ishibashi K, Takarada S, Nakanishi H, Tanaka A, Kimura K, Hirata K, Mizukoshi M, Imanishi T, Akasaka T. Impact of hinge motion on in-stent restenosis after sirolimus-eluting stent implantation. Circ J. 2011;75:1878-1884.
18. Umeda H, Gochi T, Iwase M, Izawa H, Shimizu T, Ishiki R, Inagaki H, Toyama J, Yokota M, Murohara T. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation. Int J Cardiol. 2009;133:321-326.
19. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Aoki J, Franklin-Bond T, Dasgupta N, Lansky AJ, Dan-gas GD, Stone GW, Moses JW, Mehran R, Leon MB. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol. 2009;103:818-823.
20. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007;356:1020-1029. (Pubitemid 46376802)
21. Chung WS, Park CS, Seung KB, Kim PJ, Lee JM, Koo BK, Jang YS, Yang JY, Yoon JH, Kim DI, Yoon YW, Park JS, Cho YH, Park SJ. The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation. Int J Cardiol. 2008;125:325-331.
22. Chakravarty T, White AJ, Buch M, Naik H, Doctor N, Schapira J, Kar S, Forrester JS, Weiss RE, Makkar R. Meta-Analysis of incidence, clinical characteristics and implications of stent fracture. Am J Cardiol. 2010;106:1075-1080.
23. Torguson R, Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on the Xience V Evero-limus-Eluting Coronary Stent. Am J Cardiol. 2008;102:1624-1630.
24. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA, Jr, Parise H, Mehran R, Leon MB, Moses JW, Stone GW. Intravascular ultrasound fnd-ings of stent fractures in patients with Sirolimus-And Paclitaxel-eluting stents. Am J Cardiol. 2010;106:952-957.
25. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to frst-generation sirolimus-And paclitaxel-eluting stents. J Am Coll Cardiol. 2011;57:390-398.
26. Zbinden R, Eshtehardi P, Cook S. Coronary aneurysm formation in a patient early after everolimus-eluting stent implantation. J Invasive Cardiol. 2008;20:E174-E175. (Pubitemid 351643287)
27. Williams PD, Mamas MA, Morgan KP, El-Omar M, Clarke B, Bain-bridge A, Fath-Ordoubadi F, Fraser DG. Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms. EuroIntervention. 2012;8:267-274.
28. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, De Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Impact of the everolimus-eluting stent on stent thrombosis: a meta-Analysis of 13 randomized trials. J Am Coll Cardiol. 2011;58:1569-1577.
29. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45:995-998. (Pubitemid 40432428)
30. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
31. Oyabu J, Ueda Y, Ogasawara N, Okada K, Hirayama A, Kodama K. An-gioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent. Am Heart J. 2006;152:1168-1174. (Pubitemid 44854799)
32. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligth-Art J, Regar E. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Interv. 2009;2:445-452.
33. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130. (Pubitemid 40617065)
34. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfibro JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803-2809. (Pubitemid 44305292)
35. Barlis P, Sianos G, Ferrante G, Del Furia F, D'Souza S, Di Mario C. The use of intra-coronary optical coherence tomography for the assessment of sirolimus-eluting stent fracture. Int J Cardiol. 2009;136:e16-e20.
36. Umeda H, Kawai T, Misumida N, Ota T, Hayashi K, Iwase M, Izawa H, Sugino S, Shimizu T, Takeichi Y, Ishiki R, Inagaki H, Ozaki Y, Murohara T. Impact of sirolimus-eluting stent fracture on 4-year clinical outcomes. Circ Cardiovasc Interv. 2011;4:349-354.